Literature DB >> 15241003

Effect of patient, operative and isolation factors on subsequent yield and viability of human hepatocytes for research use.

T D R Lloyd1, S Orr, R Patel, G Crees, S Chavda, H Vadyar, D P Berry, D Sherlock, A R Dennison.   

Abstract

It is widely accepted that the model of choice for pharmacotoxicological studies are human hepatocytes. There is therefore a demand for these cells, but quality must be maintained for their widespread use. We present a retrospective review of the isolation of hepatocytes from both surgically resected tissue and livers rejected for transplantation, and evaluated patient, operative and isolation variables to ascertain which may affect the viability and yield of cells. Seven clinically rejected whole livers and 60 surgically resected specimens (from two distinct operating centres) were isolated. For surgically resected tissue we found that decreasing age, securing the perfusing cannulae with suture rather than reforming Glissons capsule with glue and steatotic livers improved viability. No significant correlation could be found with pre-operative blood results, disease, type of operation, presence or absence of Pringle manoeuvre, weight of tissue isolated, time of digestion with collagenase and cold ischaemic time. There was a reduction in mean yield and viability when hepatocyte isolations were performed in livers rejected for transplant, compared to surgically resected tissue although this did not reach significance. Human hepatocytes can be successfully and consistently isolated from surgically resected tissue and appear to be superior to those isolated from rejected for transplant livers. From our study, there are few parameters that significantly affect the quality of isolated hepatocytes, which increases the possible pool of tissue that hepatocytes can be isolated from.

Entities:  

Mesh:

Year:  2004        PMID: 15241003     DOI: 10.1023/B:CATB.0000034079.10985.bd

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  10 in total

1.  Long-term culture and characterization of patient-derived primary hepatocytes using conditional reprogramming.

Authors:  Shan Su; Cristina Di Poto; Rabindra Roy; Xuefeng Liu; Wanxing Cui; Alexander Kroemer; Habtom W Ressom
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-11

2.  Effect of matrine on primary human hepatocytes in vitro.

Authors:  Xiaobing Gong; Yuan Gao; Guoqing Guo; Florian W R Vondran; Ruth Schwartlander; Ekaterina Efimova; Gesine Pless; Igor M Sauera; Peter Neuhaus
Journal:  Cytotechnology       Date:  2014-01-21       Impact factor: 2.058

Review 3.  Liver 'organ on a chip'.

Authors:  Colin H Beckwitt; Amanda M Clark; Sarah Wheeler; D Lansing Taylor; Donna B Stolz; Linda Griffith; Alan Wells
Journal:  Exp Cell Res       Date:  2017-12-29       Impact factor: 3.905

4.  How Donor and Surgical Factors Affect the Viability and Functionality of Human Hepatocytes Isolated From Liver Resections.

Authors:  Estela Solanas; Nieves Sanchez-Fuentes; Alejandro Serrablo; Alberto Lue; Sara Lorente; Luis Cortés; Angel Lanas; Pedro M Baptista; M Trinidad Serrano
Journal:  Front Med (Lausanne)       Date:  2022-05-11

5.  Expression profiling of interindividual variability following xenobiotic exposures in primary human hepatocyte cultures.

Authors:  Katy M O Goyak; Mary C Johnson; Stephen C Strom; Curtis J Omiecinski
Journal:  Toxicol Appl Pharmacol       Date:  2008-05-10       Impact factor: 4.219

6.  Clinical Hepatocyte Transplantation: What Is Next?

Authors:  James E Squires; Kyle A Soltys; Patrick McKiernan; Robert H Squires; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Curr Transplant Rep       Date:  2017-10-14

7.  An algorithm that predicts the viability and the yield of human hepatocytes isolated from remnant liver pieces obtained from liver resections.

Authors:  Serene M L Lee; Celine Schelcher; Rüdiger P Laubender; Natalja Fröse; Reinhard M K Thasler; Tobias S Schiergens; Ulrich Mansmann; Wolfgang E Thasler
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

8.  Liver tissue fragments obtained from males are the most promising source of human hepatocytes for cell-based therapies - Flow cytometric analysis of albumin expression.

Authors:  Karolina Ewa Zakrzewska; Anna Samluk; Agnieszka Wencel; Krzysztof Dudek; Dorota Genowefa Pijanowska; Krzysztof Dariusz Pluta
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240

9.  Explanted diseased livers - a possible source of metabolic competent primary human hepatocytes.

Authors:  Moritz Kleine; Marc Riemer; Till Krech; Daphne DeTemple; Mark D Jäger; Frank Lehner; Michael P Manns; Jürgen Klempnauer; Jürgen Borlak; Hueseyin Bektas; Florian W R Vondran
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

10.  Hepatocyte isolation from resected benign tissues: Results of a 5-year experience.

Authors:  Fan-Ying Meng; Li Liu; Jun Liu; Chun-You Li; Jian-Ping Wang; Feng-Hui Yang; Zhi-Shui Chen; Ping Zhou
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.